News, Insights & Expert Perspectives

Scientific Posters | December 5, 2024

Application of Binder Jetting to Develop 3D Printed Modified Release Tablets

Additive manufacturing, especially 3D printing (3DP), is revolutionizing drug delivery. This study d…

Read More

Scientific Posters | December 5, 2024

Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck SLC ® Through Z-Form Binder Jetting Technology

Many new drug substances are poorly soluble, making traditional drug development slow and costly. Th…

Read More

Scientific Posters | December 5, 2024

Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient

Explore the unique advantages of 3D printing (3DP) in creating highly porous oral disintegrating tab…

Read More

News | September 11, 2024

The Leader in Development & Manufacturing of 3D Pharmaceutical Printing: Tradeshow Flyer

Aprecia offers commercial-scale production systems designed to accelerate clinical development and o…

Read More

Webinars | September 18, 2023

Overcoming Formulation Challenges with Z-FORM Flex

Read More

Webinars | September 6, 2023

Understanding the Regulatory Environment Surrounding Pharmaceutical 3DP Technologies Webinar

Read More

Webinars | September 6, 2023

How Pharmaceutical 3DP Technologies Are Overcoming Formulation Challenges Webinar

Read More

Webinars | September 6, 2023

Science and Technology of 3DP Formulation Using Powder Bed Inkjet Technology Webinar

Read More

Webinars | September 6, 2023

Materials and Excipients For 3DP Pharma Applications Webinar

Read More

Webinars | September 6, 2023

Patient Focused Opportunities and Challenges Webinar

Read More

Webinars | September 6, 2023

Advancements and Current Deployment of 3D Printing in Pharmaceuticals and Life Sciences Webinar

Read More

Whitepapers | September 1, 2023

Redefining Fast Melt for Pharma: Achieving High Drug Load with Rapid Dispersion Using 3D Printing

Download Whitepaper

Press | April 13, 2022

Dr. Mike Gosselin Selected to Lead Aprecia’s Product Development Team

Gosselin’s science-based, solution-focused leadership will guide novel 3DP product development fro…

Read More

Press | March 8, 2022

Aprecia Selects Garry Hedgepeth To Lead Quality Team

Hedgepeth’s extensive industry experience and leadership qualities will ensure Aprecia products wi…

Read More

Press | October 20, 2021

Aprecia Announces New Leadership Team

CINCINNATI, Ohio, October 20, 2021 – Kyle Smith has been named President and Chief Operating…

Read More

Press | August 4, 2021

Purdue University And Us Pharmacopeia Launch Webinar Series On PharmaceuticAl 3D-Printing

The educational series will bring together leading 3D-Printing experts from around the globe to disc…

Read More

Press | April 21, 2021

Nanoform And Aprecia Collaborate To Advance 3D-Printed Nanomedicines

Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines Helsinki, Finland – Nano…

Read More

Press | February 23, 2021

Glatt Pharmaceutical Services and Aprecia to Advance Patient Focused Pharmaceuticals with Aprecia’s 3D-Printing Technology

Aprecia’s compression-free 3DPmanufacturing platform expands Glatt capabilities in innovative part…

Read More

Press | December 21, 2020

Aprecia Establishes a Long-Term Partnership with Battelle

CINCINNATI, Ohio and COLUMBUS, Ohio — Aprecia is partnering with Battelle to accelerate and ex…

Read More

Press | November 18, 2020

Purdue University Receives 3DP Equipment from Aprecia Pharmaceuticals

WESTLAFAYETTE, Ind. and CINCINNATI, Ohio, November 18, 2020 – Purdue University continues to…

Read More

Press | September 16, 2020

Aprecia Appoints Kathi Rinesmith Senior Vice President, Regulatory Affairs

CINCINNATI OH, September 16, 2020 – Aprecia, the 3DP Pharmaceutical Company, today announced the…

Read More

Case Studies | March 20, 2020

Additive Manufacturing: 3D-Printed Pills

Last updated on March 20, 2020 Certain medical conditions such as epilepsy need to be treated with h…

Read More

Press | February 20, 2020

3D Pharmaceutical Printing is the Focus of Aprecia-Purdue Partnership

WEST LAFAYETTE, Ind. and CINCINNATI, Ohio — Healthcare is poised for a potential giant leap forwar…

Read More

Press | March 7, 2019

Aprecia and CMIC, a Leading CDMO in Japan, have established an agreement to bring 3DP pharmaceutical products to Japan

CINCINNATI, OH and Minato-ku, Tokyo, March 7, 2019 – Privately held Aprecia Pharmaceuticals…

Read More

Press | March 22, 2016

First FDA-Approved Medicine Manufactured Using 3d Printing Technology Now Available

BLUEASH, Ohio, March 22, 2016 – Aprecia Pharmaceuticals today announced that SPRITAM®&n…

Read More

Press | August 3, 2015

FDA Approves The First 3d Printed Drug Product

BLUE ASH, Ohio, August 3, 2015 – Aprecia Pharmaceuticals Company today announced that the U.S…

Read More

Press | February 23, 2015

Pharmaceutical Company Moving Its Manufacturing Operations to Blue Ash

Blue Ash, OH (2/23/2015) – A U.S.-based pharmaceutical company will be bringing new jobs to t…

Read More

Press | December 9, 2014

Aprecia Pharmaceuticals Receives FDA Acceptance For Filing For First Product Using Advanced Zipdose® Technology

LANGHORNE, Pa, December 9, 2014 — Aprecia Pharmaceuticals announced today that the U.S. F…

Read More